Central Securities Corp Holding in Medtronic Plc (MDT) Has Cut by $4.25 Million as Valuation Rose

Medtronic plc (NYSE:MDT) LogoInvestors sentiment decreased to 0.98 in Q2 2018. Its down 0.10, from 1.08 in 2018Q1. It dived, as 49 investors sold MDT shares while 436 reduced holdings. 99 funds opened positions while 374 raised stakes. 1.03 billion shares or 0.70% less from 1.04 billion shares in 2018Q1 were reported. Pennsylvania Trust accumulated 71,526 shares. Cheviot Value Mngmt Limited Liability Com has 2.48% invested in Medtronic plc (NYSE:MDT). Moreover, Howe Rusling Inc has 1.3% invested in Medtronic plc (NYSE:MDT) for 84,212 shares. The Texas-based Linscomb And Williams has invested 0.21% in Medtronic plc (NYSE:MDT). Regions Fin accumulated 82,473 shares. Brown Advisory Secs Ltd Liability Company reported 0.08% stake. Franklin Resource reported 1.59% of its portfolio in Medtronic plc (NYSE:MDT). Oakworth Cap holds 2,787 shares. Glenmede Tru Na owns 231,929 shares. Argyle Cap Mngmt Inc invested 1.57% of its portfolio in Medtronic plc (NYSE:MDT). Parsec Management invested in 0.01% or 2,510 shares. Mitchell Sinkler And Starr Pa has 0.49% invested in Medtronic plc (NYSE:MDT). Novare Capital Mngmt Limited Liability accumulated 92,191 shares or 1.34% of the stock. Mufg Americas Holdings Corporation holds 0.49% of its portfolio in Medtronic plc (NYSE:MDT) for 185,357 shares. Ntv Asset Mngmt Limited Company invested 0.26% of its portfolio in Medtronic plc (NYSE:MDT).

Central Securities Corp decreased its stake in Medtronic Plc (MDT) by 20% based on its latest 2018Q2 regulatory filing with the SEC. Central Securities Corp sold 50,000 shares as the company’s stock rose 12.13% with the market. The institutional investor held 200,000 shares of the electromedical & electrotherapeutic apparatus company at the end of 2018Q2, valued at $17.12 million, down from 250,000 at the end of the previous reported quarter. Central Securities Corp who had been investing in Medtronic Plc for a number of months, seems to be less bullish one the $131.29 billion market cap company. The stock increased 0.96% or $0.93 during the last trading session, reaching $97.53. About 6.58M shares traded or 29.15% up from the average. Medtronic plc (NYSE:MDT) has risen 16.95% since December 2, 2017 and is uptrending. It has outperformed by 1.33% the S&P500.

Central Securities Corp, which manages about $642.09 million US Long portfolio, upped its stake in Alphabet Inc by 3,000 shares to 15,000 shares, valued at $16.94M in 2018Q2, according to the filing.

More notable recent Medtronic plc (NYSE:MDT) news were published by: Benzinga.com which released: “Medtronic, Inc. (NYSE:MDT) – Medtronic’s Q2 Earnings Preview – Benzinga” on November 19, 2018, also Globenewswire.com with their article: “Medtronic to Acquire Nutrino Health NYSE:MDT – GlobeNewswire” published on November 21, 2018, Forbes.com published: “Diabetes Will Lead Medtronic’s Near Term Earnings Growth – Forbes” on November 23, 2018. More interesting news about Medtronic plc (NYSE:MDT) were released by: Seekingalpha.com and their article: “Medtronic slips 2% premarket on device injuries – Seeking Alpha” published on November 26, 2018 as well as Seekingalpha.com‘s news article titled: “Surprising Medtronic Is Making Strides – Seeking Alpha” with publication date: November 23, 2018.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 13 analysts covering Medtronic (NYSE:MDT), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 62% are positive. Medtronic has $120 highest and $88 lowest target. $106.33’s average target is 9.02% above currents $97.53 stock price. Medtronic had 15 analyst reports since June 6, 2018 according to SRatingsIntel. The company was maintained on Monday, October 8 by Argus Research. The company was maintained on Friday, August 24 by Citigroup. Wells Fargo maintained Medtronic plc (NYSE:MDT) rating on Wednesday, August 22. Wells Fargo has “Market Perform” rating and $101 target. The rating was reinitiated by William Blair with “Market Perform” on Wednesday, June 6. As per Wednesday, August 22, the company rating was maintained by Morgan Stanley. On Wednesday, August 22 the stock rating was maintained by Stifel Nicolaus with “Hold”. The stock has “Buy” rating by Bank of America on Wednesday, August 22. The company was maintained on Monday, August 27 by Argus Research. The rating was maintained by Bank of America with “Buy” on Wednesday, June 6. As per Wednesday, November 21, the company rating was maintained by Raymond James.

Medtronic plc (NYSE:MDT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.